Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study | Zendy

Arnaud Benahmed | Zendy; M. Kianda | Zendy; Lidia Ghisdal | Zendy; Nilüfer Broeders | Zendy; Annick Massart | Zendy; A. Lemy | Zendy; Dimitri Mikhalski | Zendy; Anh Hoang | Zendy; Vincent Donckier | Zendy; Claude Sadis | Zendy; Alaín Le Moine | Zendy; P. Madhoun | Zendy; Judith Racapé | Zendy; Martin Wissing | Zendy; Daniel Abramowicz | Zendy

Open Access

Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study

Author(s) -

Arnaud Benahmed,

M. Kianda,

Lidia Ghisdal,

Nilüfer Broeders,

Annick Massart,

A. Lemy,

Dimitri Mikhalski,

Anh Hoang,

Vincent Donckier,

Claude Sadis,

Alaín Le Moine,

P. Madhoun,

Judith Racapé,

Martin Wissing,

Daniel Abramowicz

Publication year - 2013

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gft385

Subject(s) - medicine , clopidogrel , ticlopidine , aspirin , transplantation , contraindication , surgery , kidney transplantation , alternative medicine , pathology

Patients undergoing kidney transplantation are sometimes being treated with antiplatelet agents such as ticlopidine or clopidogrel. Some teams refuse to wait-list these patients for fear of bleeding during transplant surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research